Home |
Free Dividend Report |
Stock Splits Calendar |
NGM Historical Stock Prices |
Preferred Stock Newsletter |
NGM Options Chain |
Stock Message Boards |
NGM Biopharmaceuticals (NGM) has the following price history information. Looking back at NGM historical stock prices for the last five trading days, on March 21, 2024, NGM opened at $1.55, traded as high as $1.57 and as low as $1.54, and closed at $1.56. Trading volume was a total of 1.03M shares. On March 22, 2024, NGM opened at $1.56, traded as high as $1.58 and as low as $1.54, and closed at $1.55. Trading volume was a total of 1.56M shares. On March 25, 2024, NGM opened at $1.56, traded as high as $1.60 and as low as $1.55, and closed at $1.55. Trading volume was a total of 1.36M shares. On March 26, 2024, NGM opened at $1.55, traded as high as $1.57 and as low as $1.55, and closed at $1.55. Trading volume was a total of 771.00K shares. On March 27, 2024, NGM opened at $1.55, traded as high as $1.63 and as low as $1.53, and closed at $1.62. Trading volume was a total of 3.30M shares.
NGM Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into NGM Biopharmaceuticals shares, starting with a $10,000 purchase of NGM, and working forward through the historical stock price information to today.
Growth of $10,000.00 Without Dividends Reinvested |
||
Start date: | 04/05/2019 | |
End date: | 03/27/2024 | |
Start price/share: | $15.10 | |
End price/share: | $1.62 | |
Dividends collected/share: | $0.00 | |
Total return: | -89.27% | |
Average Annual Total Return: | -36.12% | |
Starting investment: | $10,000.00 | |
Ending investment: | $1,072.90 | |
Years: | 4.98 |
NGM Historical Price Range | |||||
Date | Open | High | Low | Close | Volume |
03/21/2024 | $1.55 | $1.57 | $1.54 | $1.56 | 1.03M |
03/22/2024 | $1.56 | $1.58 | $1.54 | $1.55 | 1.56M |
03/25/2024 | $1.56 | $1.60 | $1.55 | $1.55 | 1.36M |
03/26/2024 | $1.55 | $1.57 | $1.55 | $1.55 | 771.00K |
03/27/2024 | $1.55 | $1.63 | $1.53 | $1.62 | 3.30M |
About NGM Biopharmaceuticals |
NGM Biopharmaceuticals is a biopharmaceutical company. Co. has five product candidates in the clinic, three wholly-owned by Co. (NGM707, NGM120 and aldafermin), one being progressed by its collaborator, Merck Sharp & Dohme Corp., or Merck (MK-3655) and one optionable by Merck (NGM621). Co.'s oncology product candidates include NGM707, NGM831, NGM438 and NGM120 and their related compounds. NGM621 was engineered to bind to, and be a long-acting inhibitor of, complement C3 with the treatment goal of reducing disease progression in patients with geographic atrophy, secondary to age-related macular degeneration. MK-3655 isin Phase 2b development for the treatment of nonalcoholic steatohepatitis. |
NGM Historical Closing Prices | |
Date | Close |
03/21/2024 | $1.56 |
03/22/2024 | $1.55 |
03/25/2024 | $1.55 |
03/26/2024 | $1.55 |
03/27/2024 | $1.62 |
Materials Historical Prices |
NGM is categorized under the Materials sector; below are some other companies in the same sector:
NGVT Historical Stock Prices
Free NGM Email Alerts:
|
NGM Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2024, All Rights Reserved
Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.Want to receive our latest research absolutely free?
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.